Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,161 | -2,844 | -1,861 | -1,176 | -1,901 |
| Depreciation Amortization | 200 | 100 | 625 | 92 | 60 |
| Accounts receivable | -814 | 3,302 | -1,693 | -1,395 | 932 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 1,236 | N/A |
| Other Working Capital | -1,093 | 3,584 | -3,072 | -1,406 | -648 |
| Other Operating Activity | 2,504 | -2,429 | 3,972 | 2,254 | 740 |
| Operating Cash Flow | $-364 | $1,713 | $-2,029 | $-395 | $-817 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -51 | -51 | -51 |
| Purchase Of Investment | -15,072 | -15,109 | N/A | N/A | N/A |
| Investing Cash Flow | $-15,072 | $-15,109 | $-51 | $-51 | $-51 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 616 | 580 | 20,685 | 685 | 685 |
| Other Financing Activity | 0 | 0 | -1,316 | 0 | 0 |
| Financing Cash Flow | $616 | $580 | $19,369 | $685 | $685 |
| Exchange Rate Effect | 12 | 15 | -19 | -116 | -296 |
| Beginning Cash Position | 48,251 | 48,251 | 30,981 | 30,981 | 30,981 |
| End Cash Position | 33,443 | 35,450 | 48,251 | 31,103 | 30,502 |
| Net Cash Flow | $-14,808 | $-12,802 | $17,271 | $123 | $-478 |
| Free Cash Flow | |||||
| Operating Cash Flow | -364 | 1,713 | -2,029 | -395 | -817 |
| Capital Expenditure | N/A | N/A | -51 | -51 | -51 |
| Free Cash Flow | -364 | 1,713 | -2,080 | -446 | -868 |